Comparisons & landscape

Peptide research library

Independent comparisons across the GLP-1, GIP and glucagon triagonist research landscape. Each piece sticks to mechanism, trial data and dosing structure — not therapeutic claims. Updated as new Phase 2/3 readouts publish.

For in-vitro laboratory research only. Not for human or veterinary use.

Articles

Comparison Retatrutide vs Tirzepatide Receptor count, weight-loss readouts, dose ladder, half-life — the practical differences a researcher comparing the two should hold in their head. Landscape Triagonist Landscape 2026 Where retatrutide, cagrisema, survodutide and orforglipron sit against each other on receptor design, trial stage, and dose architecture.

Adjacent resources

Verification COA Library Independent Janoshik reports for every Retatrutide batch with verification keys. Tools Research tools Dose-titration scheduler and pen-clicks-to-mg converter for retatrutide research. Long-form Remy Peptides research library Approval trackers, mechanism deep-dives, and 50+ existing articles on the commercial site.